Main Category: Arthritis / Rheumatology
Article Date: 24 Mar 2011 – 12:00 PDT
email to a friend printer friendly opinions
<!– rate article
Patient / Public:Healthcare Prof:
The rheumatology program at NewYork-Presbyterian Hospital/Columbia University Medical Center is expanding with the addition of one of the nation’s leading rheumatologists, the creation of a new integrated Arthritis Center, and plans for additional disease-specific centers.
Dr. Joan Bathon has been appointed director of the Division of Rheumatology at NewYork-Presbyterian Hospital/Columbia University Medical Center and professor of medicine at Columbia University College of Physicians and Surgeons. Previously, she was deputy director of the Division of Rheumatology and director of the Arthritis Center at Johns Hopkins.
Also joining NewYork-Presbyterian/Columbia from Johns Hopkins are Drs. Jon T. Giles and Dimitrios Pappas — both leading experts in rheumatoid arthritis.
The new Arthritis Center at NewYork-Presbyterian/Columbia will specialize in inflammatory arthritis such as rheumatoid arthritis and spondyloarthritis, crystal arthritis such as gout, as well as degenerative arthritis or osteoarthritis. One of the centerpieces of its clinical offerings will be a state-of-the-art injection clinic that employs ultrasound technology to identify the specific structures behind a patient’s pain, allowing for more targeted treatments.
Multidisciplinary collaborations with other medical specialties — including cardiology, nephrology, obstetrics and orthopedic surgery — will be the key to the success of the Division of Rheumatology’s new integrated programs. “Rheumatoid conditions affect numerous areas in a patient’s body, making a multidisciplinary approach central to effective treatment, as well as to research into future therapies,” says Dr. Bathon.
For patients with lupus, Dr. Bathon and her team will work closely with nephrology and obstetrics since the disease is associated with increased risk for renal disease and pregnancy loss. For patients with arthritis, which is associated with risk for cardiovascular disease, Dr. Bathon envisions the establishment of a Cardiovascular Risk Management Clinic with cardiology to prevent and manage heart disease, and to serve as a hub for research efforts.
An authority on the arthritis-related cardiovascular risk, Dr. Bathon is pursuing NIH-funded studies into genetics biomarkers, proteomics biomarkers, and PET and CT heart imaging. She is also looking at how a class of rheumatoid arthritis drugs called TNF blockers affects heart structure and function.
“I was delighted to recruit Dr. Bathon as chief of Rheumatology. We fully embrace her vision to create disease-specific programs in which patients with arthritis, lupus or other rheumatoid conditions can receive state-of-the-art, coordinated care from a multidisciplinary team of specialists,” says Dr. Donald W. Landry, chairman of the Department of Medicine and the Samuel Bard Professor of Medicine at Columbia University College of Physicians and Surgeons, and physician-in-chief at NewYork-Presbyterian Hospital/Columbia University Medical Center. “Patients can also look forward to new treatments and prevention strategies made possible through innovative research by Dr. Bathon and her team.”
Dr. Joan Bathon received her M.D. and completed an internship and residency at the University of Maryland in Baltimore. She completed a fellowship in rheumatology at Johns Hopkins in Baltimore. In 1983, she joined the faculty of West Virginia University in Morgantown, W.V. In 1986, she joined the faculty of Johns Hopkins. In 1998, she was appointed director of the Johns Hopkins Arthritis Center, and in 2007, she was named deputy director of their Division of Rheumatology. In 2010, she was named editor-in-chief of the journal Arthritis and Rheumatism.
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.
Follow us on Twitter
Arthritis / Rheumatology headlines
email to a friend
printer friendly version
personalize your news
back to top
Please note that we publish your name, but we do not publish your email address. It is only used to let
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Terms and Conditions
MediLexicon International Ltd
MediLexicon International Ltd © 2004-2011 All rights reserved.